Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USP

This article was originally published in The Tan Sheet

Executive Summary

U.S. Pharmacopeia soliciting suggestions as it sets its goals, strategies and policies from 2000 through 2005. Resolutions will be considered by USP Convention members during the quinquennial meeting April 12-16 in Washington, D.C. Guidance suggestions should build upon USP's preliminary strategic plan for 2000-2003, which lists among its goals establishment of compendial standards for dietary supplements and maintenance and establishment of new National Formulary monographs for the most commonly used excipients in dosage forms of pharmaceuticals, biologicals and dietary supplements. Also, USP's first monograph on a botanical dosage form (ginkgo biloba tablet) will appear in the November/December issue of Pharmacopeial Forum

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090396

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel